NEW YORK, August 5, 2026, 17:07 EDT
- Axon reported second-quarter revenue up 35% to $904 million, while adjusted EBITDA surpassed consensus by 9.8%.
- Shares dropped 6.5% in after-hours trading, coming after a five-day surge of 14.7%.
- Midpoint of preliminary guidance suggests second-half growth of 31.7%.
Shares of Axon Enterprise NASDAQ:AXON declined 6.5% to $569.90 in after-hours trading on Wednesday. The stock slid even after the company reported stronger-than-expected earnings and lifted its revenue outlook. Shares finished regular trading at $609.49, rising 0.4%.
Market reaction indicates investors keyed in on the pace for the back half of the year. Axon’s updated guidance points to growth between 29.8% and 33.5% during that time. The midpoint, 31.7%, comes in under the second quarter’s 35.3% rate.
Initial revenue bridge
| Metric | Low case | Midpoint | High case |
|---|---|---|---|
| 2026 revenue increase | 32.0% | 33.0% | 34.0% |
| Projected 2026 revenue | $3.669 bln | $3.697 bln | $3.725 bln |
| Projected H2 2026 revenue | $1.957 bln | $1.985 bln | $2.013 bln |
| Implied H2 annual growth | 29.8% | 31.7% | 33.5% |
| Q2 growth as reported | 35.3% | 35.3% | 35.3% |
Initial estimates are based on disclosed 2025 sales of $2.7795 billion and sales figures from the first half of 2025 and 2026.
The deceleration is slight. Despite this, the stock rose 14.7% across five sessions. The report faced elevated expectations.
The company surpassed all major projections for the quarter. Revenue came in 3.3% above consensus. Adjusted EBITDA topped estimates by 9.8%, and adjusted earnings were 2% higher than expected.
Second-quarter earnings summary
| Metric | Q2 2026 | Benchmark | Difference |
|---|---|---|---|
| Revenue | $904.4 mln | $875.9 mln consensus | +3.3% |
| Adjusted EPS | $1.88 | $1.84 consensus | +2.0% |
| Adjusted EBITDA | $242.0 mln | $220.4 mln consensus | +9.8% |
| Operating margin | 5.2% | Negative 0.2% in Q2 2025 | +540 bps |
| Free cash flow | Negative $1.0 mln | Negative $110.7 mln in Q2 2025 | +$109.7 mln |
Consensus forecasts and annual comparisons were provided right after the announcement.
Growth remained steady. Software and services increased by 36% to $398 million. Connected devices climbed 35% to $507 million. AI Era revenue surged almost 700%, and Dedrone sales exceeded $100 million.
Forward demand showed improvement. Annual recurring revenue climbed 39% to $1.639 billion. Net revenue retention was 126%. Future contracted bookings grew 41%, totaling $15.1 billion.
Comparison of Forward Demand
| Metric | Q2 2025 | Q1 2026 | Q2 2026 | Year-on-year change |
|---|---|---|---|---|
| Annual recurring revenue | $1.183 bln | $1.493 bln | $1.639 bln | +39% |
| Net revenue retention | 124% | 125% | 126% | up 2 percentage points |
| Future contracted bookings | $10.7 bln | $14.3 bln | $15.1 bln | +41% |
The bookings balance is roughly 4.1 times the midpoint of Axon’s projected 2026 sales. The company anticipates completing 20%-25% of this in the next 12 months, with the majority to be delivered throughout the subsequent 10 years.
Profit quality remains less reassuring for investors. Overall gross margin was unchanged at 60.4%. Software gross margin declined by 430 basis points, reaching 71.3%. Device margins improved by 330 basis points, largely due to tariff refunds.
The disparity between GAAP and adjusted figures continued to be significant. Net margin for Q2 stood at 3.3%, compared to an adjusted EBITDA margin of 26.8%. Stock-based compensation reached $144.3 million. Free cash flow was marginally negative.
The response was intensified by valuation. Early after-hours estimates put Axon’s value at roughly 12.4 times its projected sales. The figures also suggest around 50 times its guided adjusted EBITDA. The estimate is based on 80.6 million shares and net debt of $1.1 billion.
Axon finished Wednesday with a price-to-earnings ratio around 244 based on trailing earnings. By comparison, Motorola Solutions NYSE:MSI, its main large publicly listed rival, traded at close to 35 times. Axon’s higher growth rate and larger involvement in software help justify that valuation gap.
Prior to earnings, TheStreet Pro’s Bob Lang described the chart as “bullish.” He also pointed out soft money flow and a negative MACD. The portfolio recommended “stockpile on pullbacks” on Axon and revealed a long position. TheStreet Pro
Sell-side analysts showed mostly positive sentiment. According to FactSet, 21 out of 23 analysts rated the stock positively. Their average price target stood at $688.65, about 21% higher than the after-hours price. These targets were set before revisions following the Q2 results.
Analyst ratings prior to post-Q2 adjustments
| Recommendation | Current count | One month earlier |
|---|---|---|
| Buy | 17 | 17 |
| Overweight | 4 | 4 |
| Hold | 1 | 2 |
| Underweight | 1 | 1 |
| Sell | 0 | 0 |
| Consensus | Buy | Buy |
Analysts on average set a target of $688.65, while the median forecast stood at $700, with projections ranging from $440 to $825.
The closed cash market had already reflected expectations of a robust result. Axon surged 14.7% in the five sessions up to Wednesday. At $569.90, shares were still trading 8.5% higher than their July 30 close.
The upcoming week starts with the August 6 cash session. Market participants will track estimate revisions, software profitability, and the pace of backlog conversion. The steady 25.5% EBITDA objective keeps the spotlight on delivery.
Risks: Bookings feature extended agreements and some provisions for termination. Axon projects stock-based compensation of $590 million to $620 million in 2026. The midpoint is roughly 64% of its guided adjusted EBITDA.
Demand is still strong. The next step relies on turning that demand into cash flow and GAAP profitability.
Did Axon’s second-quarter results meet analyst expectations?
Revenue totaled $904.4 million, marking a 35% increase and beating consensus estimates by 3.2%. Non-GAAP diluted EPS came in at $1.88, roughly 2% higher than the $1.84 forecast. Axon has reported revenue growth above 30% for ten consecutive quarters.
By what amount did management lift its 2026 forecast?
Axon raised its revenue growth outlook to 32%–34%, up from a previous range of 30%–32%. The midpoint increased by two points, while EBITDA margin guidance was left unchanged at 25.5%. Despite boosting its sales forecast, management maintained the same margin target.
Does recurring software revenue support more sustainable growth?
Annual recurring revenue climbed 39% to $1.639 billion. Net revenue retention was 126%. Software and Services revenue increased 36%, totaling $398 million. Revenue from AI Era surged almost 700%, but Axon did not specify an amount. However, segment gross margin dropped 430 basis points to 71.3%.
Have the latest growth drivers become financially significant?
Revenue from Platform Solutions soared 123% to $150 million, with Dedrone contributing over $100 million. Future contracted bookings climbed 41% to reach $15.1 billion. Axon anticipates delivering 20%–25% of these bookings in the next twelve months, with most of the rest expected to be recognized over the subsequent decade.
Are profit and cash conversion progressing at the same rate?
Adjusted EBITDA climbed more than 40% to $242 million, representing a 26.8% margin. GAAP net income came in at $29 million, accounting for 3.3% of revenue. Free cash flow totaled negative $1 million, and net debt stood at $1.1 billion. Stock-based compensation guidance is unchanged at $590–$620 million, equivalent to about 16%–17% of projected sales.
Is the earnings beat already reflected in the stock price?
Regular trading has not resumed. AXON finished at $609.49 on August 5, before releasing earnings. Google reported its market capitalisation at $48.94 billion at that close. That represented roughly 13 times the mid-point of updated 2026 sales guidance. The most recent confirmed quote remained from August 5, not August 6 trading.
